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Abstract
Aim: The purpose of this study was to investigate the relationship between executive functions and thyroid
ultrasound parameters in remitted bipolar patients who were on lithium treatment. Methods: In the current study, 25
remitted patients with diagnoses of Bipolar I Disorder having blood lithium, and thyroid hormone levels within the
normal range were consecutively enrolled. Healthy control group consisted of 25 euthyroid people matched as an
age, sex and education level with the patients. Semi-structured sociodemographic and clinical form, the Structured
Clinical Interview for DSM-IV Axis I Disorders, the Montreal Cognitive Assessment (MoCA), the Hamilton Depression
Scale , Young Mania Rating Scale, thyroid ultrasonography and the Wisconsin Card Sorting Test (WCST) were
applied to both groups. Within the patient group, correlation analysis was performed between WCST performance
and thyroid volume. Results: In the present study, no significant difference was found between the bipolar and the
healthy control groups regarding the executive functions as measured via WCST. In the bipolar patients, there were
no statistically significant correlations among WCST scores and thyroid volumes. Conclusion: Thyroid volumes are
not appeared to be associated with executive functions in euthymic bipolar patients.
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Introduction
It is known that the most frequent affects of lithium on the thyroid
are hypothyroidism and goiter [1]. The most commonly observed
cognitive impairments associated with hypothyroidism include
amnesia, attention deficit, slowed processing speed and depressed
mood [2]. Executive functions concerns with the higher-level cognitive
skills. Additionally, high TSH values can cause a reduction in cognitive
functions [3].
Although cognitive impairment is well-defined in clinical
hypothyroidism [4], there are some conflicting reports on cognitive
changes in subclinical hypothyroidism [5,6]. Benign non-toxic diffuse
goiter has been reported in individuals using lithium for long periods,
with rates ranging between 3.8 and 51% [7-14]. It is important to
answer the question whether TSH-suppression treatment should be
initiated immediately after the diagnosis of goiter in patients treated
with lithium [15]. Monitoring changes in thyroid volumes with
thyroid ultrasonography is recommended when goiter is diagnosed in
lithium therapy [16-18]. Studies have indicated that lithium treatment
is a risk factor for increased thyroid volume in patients with bipolar
disorder, and these patients may be monitored with thyroid
ultrasonography at the baseline and follow-up [5,19-23]. Even though
hypothyroidism is associated with cognitive dysfunctions in the
literature, the effects of thyroid volume enlargement without
hormonal changes are not comprehensively investigated.
It is known that lithium may cause hypothyroidism and that
executive functions are also affected in patients developing
hypothyroidism. Subclinical hypothyroidism has been psychiatrically 
investigated, and studies have been conducted investigating its 
relationship with executive functions. However, the effects of the 
changes in thyroid parameters measured by thyroid ultrasonography 
before these changes in hormone levels have occurred are not clear. In 
the current study, we hypothesized those ultra-sound measurements of 




Twenty-five patients with DSM-IV diagnoses of Bipolar I Disorder
who were receiving treatment and follow-up therapy in outpatient
settings were consecutively included in this study. The control group
consisted of 25 subjects who were eligible based on study criteria.
Patients with bipolar disorder who were euthymic (YMRS score of <5,
HAM-D score of <7) for at least 8 weeks and who had at least two
blood lithium levels measured within the last 6 months at normal
limits (0.6-1.2 meq/l) were included in the study. Five out of 30
subjects in the patient group and 6 out of 31 subjects in the control
group were excluded from study due to detection of nodules in thyroid
USG imaging. Written consents of the patient and control groups and
ethical committee approval for the study were obtained.
Patients were included if they had been in remission for at least two 
months and had free thyroxine (fT4), free triiodothyronine (fT3), and 
Thyroid-stimulating hormone (TSH) values at normal limits (TSH: 
0.35–4.94 uI U/ml; fT3: 1.71-3.71 pgr/mL; fT4: 0.70-1.48 ng/dL). 
Exclusion criteria for the study included education and language
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problems preventing administration of the diagnostic psychiatric
interview, scores of <21 in the MoCA test, diagnosis of any
degenerative neurological disorder, dementia, mental retardation,
epilepsy, cerebral tumors or cerebrovascular disease, history of head
trauma causing loss of consciousness, endocrine disease, any
concurrent axis I psychiatric diagnosis, diagnosis of alcohol or
substance dependence within the last year, contraindications against
the ultrasonography procedure (e.g., a significant wound scar or tissue
defect on the neck that deteriorated or limited the extension and
acoustic permeability of neck), pregnancy, electroconvulsive therapy
(ECT) within last 6 months, fT4, fT3, or TSH values outside of normal
limits and nodules, masses or abnormal vascularization in thyroid
ultrasonography. Subjects in the control group were between 18 and
65 years, had fT4, fT3, and TSH values at normal limits and met
inclusion using similar evaluation criteria to those applied to the
patient group.
Thyroid function tests measuring fT4, fT3, and TSH levels were
administered at the same laboratory for both patients and control
group subjects. Axis I or any other diagnosis was determined using the
SCID-I, which was established for patients and healthy controls.
Groups were compared with respect to their WCST performances. The
correlation between WCST performance and thyroid volumes of the
patient group was investigated.
Measurements
Socio-demographic and clinical characteristics data form
Variables such as gender, age, marital status, education, work status,
income status, age at onset of bipolar disorder, drug use, and history of
familial psychiatric disease were incorporated in a semi-structured
form developed by investigators to include socio-demographic and
clinical characteristics.
Wisconsin Card Sorting Test (WCST)
The WCST is test for assessing executive functions [24]. The test
evaluates decision-making and flexibility, responsiveness to feedback
and problem-solving skills of an individual [25]. A computerized form
of the test was used in this study. A key card and four response cards,
which are similar to key card but have differences in color, geometric
shape and number, appear on the screen. Participants are told to
match each response card with the key cards. After each match,
feedback (“right” or “wrong”) is given. Following 10 consecutive
correct answers, the desired matching principle is changed without
warning. The participant is told to match the cards according to the
change made. There are no time limitations placed on the test; it
continues until the completion of six categories or 64 attempts.
Montreal Cognitive Assessment (MoCA)
The MoCA was developed as a quick scan test for mild cognitive
impairment by assessing different cognitive functions. These functions
include attention and concentration, executive functions, memory,
language, visual constitution skills, abstract thinking, calculation and
orientation. The maximum score of the test is 30.
Accordingly, scores of ≥21 are considered within normal limits [26].
Hamilton Depression Rating Scale (HAM-D)
This scale was developed by Hamilton toassess severity of
depressive symptoms in patients diagnosed with depression and is
administered by an interviewer. A Turkish validity and reliability
study was conducted by Akdemiret al. [27].
Young Mania Rating Scale
This scale was developed by Young et al. in 1978 to measure these
verities in and change of manic state and is administered by an
interviewer. It is composed of a total of 11 items. A Turkish validity
and reliability study was conducted by Karadag et al. [28].
SCID-I
This structured interview was developed to facilitate DSM-IV Axis I
diagnosis [29]. A Turkish reliability and validity study was conducted
by Çorapçıoğlu et al. [30].
SCID-I/NP
This semi-structured clinical interview tool was developed to
exclude DSM-III-R diagnoses 31. The Turkish adaptation was
conducted by Sorias et al. [32].
Thyroid Ultrasonography
Thyroid sonographies were performed by the same radiologistusing
a VFX 9-4 multi-D matrix probe ultrasonography device by Siemens
Acuson Antares (Siemens, USA). The central frequency was adjusted
to 7 mHz, with the probe having a frequency range of 4 to 9 mHz, and
the transverse and anteroposterior lengths on the axial plane and the
craniocaudal length on the sagittal plane were measured for both
thyroid lobes using an electronic ruler.
Statistical analysis
Statistical analyses for the study were performed with the SPSS 
14.00program. In statistical evaluations of study data, chi-square tests 
were used to assess the relationships between definitive methods (i.e., 
frequency, median, and standard deviation) and categorical variables. 
Chi-square tests and Mann-Whitney U tests were used to compare 
non-parametric values. Spearman correlation analysis was applied to 
determine relationships between the variables. The significance level 
was established as p<0.05.
Results
Socio-demographic characteristics
No differences were found between the patient group and the 
control group with respect to gender, age or education (p>0.05). Mean 
age was 34.68 ± 7.83 years for the patient group and 33.00 ± 5.45 for 
the control group. There were 11 female (44%) and 14 male patients 
(56%) in the patient group and 11 female (44%) and 14 male patients 
(56%) in control group. Duration of education was 11.48 ± 4.18 years 
for the patient group and 12.20 ± 4.12 for the control group.
Clinical characteristics
All patients were receiving treatment and follow-up therapy for the
diagnosis of Bipolar I Disorder, and their average disease duration was
11.00 ± 6.73 years. The mean age at onset of the disease was 23.68 ±
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9.25 years. All patients were using lithium, and the mean duration of 
lithium use was 77.00 ± 59.49 months. The mean number of episodes 
was 4.72 ± 2.38, the mean number of manic episodes was 2.76 ± 1.36, 
the mean number of depressive episodes was 1.96 ± 1.76 and the mean 
number of mixed episodes was 0.04 ± 0.20. When evaluated for 
psychotic features, the mean number of manic episodes with psychotic 
features was 1.28 ± 1.10, the mean number of depressive episodes with 
psychotic features was 0.76 ± 1.20 and the mean number of mixed 
episodes with psychotic features was 0.04 ± 0.20. The mean number of 
hospitalizations for those in the patient group was 1.40 ± 1.11.
Of the first-degree relatives of the patients, 8 individuals had bipolar
disorder (32%), 2 individuals had schizophrenia (8%), 3 individuals
had an anxiety disorder or a depressive disorder (12%) and 12
individuals (48%) had no psychiatric history. None of the patients
used drugs. Thirteen (52%) of the patients were smokers. Five (20%)
patients had a history of alcohol use; however, they did not meet
dependency or abuse criteria. One (4%) patient had one suicide
attempt and 1 (4%) patient had two suicide attempts. Twenty-three
(92%) patients had no history of suicide attempt. Only one patient had
hypertension as a medical disease, and 7 (28%) patients had a family
history of alcohol or drug use. The periods of longest remission among
patients were 6-12 months for 3 patients (12%), 12-24 months for 4
patients (16%) and ≥ 24 months for 18 patients (72%).
Eight patients (32%) were using lithium alone, 15 patients (60%)
were using a lithium + antipsychotic combination, and 2 patients (8%)
were using a lithium + antipsychotic + antidepressant combination.
Comparison of Thyroid Measurements
USG parenchymal echo patterns in patient group were found to be
homogeneous in 21 subjects (84%), minimally heterogeneous in 1
subject (4%) and remarkably heterogeneous in 3 subjects (12%). USG
parenchymal echo patterns in the control group were found to be
homogeneous in 23 subjects (92%) and minimally heterogeneous in 2
subjects (8%). When patient and control groups were compared across
thyroid measurements, statistically significant differences were found
in all measurements except for the thyroid USG right lobe sagittal
diameter (z=1.50,p=0.13) and the thyroid USG left lobe sagittal
diameter (z=0.77; p=0.43). Thyroid diameters were larger in bipolar
patients (Table 1).
Neuropsychological Assessment:
The mean MoCA score was 26.44 ± 2.43 in the patient group and 
27.32 ± 2.21 in the control group. A significant difference (z=-1.60, 
p=0.10) was not found when the average MoCA test scores for both of 
the groups were compared. Although the patient group had lower 
Performance in all sub-parameters of the WCST test compared to 
healthy controls, no statistically significant difference was found 
between two groups (p>0.05) (Table 2).
Comparison of Thyroid USG Measurements and WCST
Results of Patient and Control Groups
All correlations among WCST scores and thyroid volume
measurements were considered to be statistically insignificant (p>0.05)
(Table 3).
Discussion
In the current study, although the euthymic patients with bipolar 
disorder using lithium had lower performance in all subcategories of 
WCST test, no statistically significant differences were found between 
the patient and control groups. Furthermore, no significant 
correlations between measures of perseveration on the WCST and 
thyroid volumes were found in bipolar patients. Complex (executive) 
attention, determination of features, perseveration, working memory, 
executive functioning, conceptualization and abstract thinking are 
measured by the WCST [33-35].
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Table 1: Comparisons of thyroid USG measurements between the
patient and control groups
Perseveration is the main abnormality in WCST and it was not 
found to be associated with thyroid volume in euthymic bipolar 
patients using lithium. In light of this information, one can think that 
increased thyroid volumes do not signify a failure in executive 
functions as measured via WCST performance in euthymic bipolar 
patients using lithium. However, this should be confirmed in larger 
samples. When the patient and control groups were compared across 
thyroid measurements, statistically significant differences were found 
in all thyroid measurements, with thyroid volumes being greater 
among bipolar patients except in the cases of the thyroid USG right 
lobe sagittal diameter and the thyroid USG left lobe sagittal diameter. 
Other conditions exist that require the use of imaging in addition to 
biochemical and immunological methods in monitoring possible 
changes in the thyroid gland; the use of thyroid ultrasonography is 
recommended, for example, for following up on the changes occurring 
in thyroid volume when goiter is diagnosed [20]. In a study conducted 
by Özsoy et al. that compared bipolar patients using or not using 
lithium with healthy controls, findings similar to ours were reported: 
namely, that increases in volume and thyroid hormone changes 
measured by ultrasonography were greater in the group not using 
lithium compared to the healthy controls and in the patient group 
using lithium compared to the patient group not using lithium.
Moreover, they recommended the use of thyroid ultrasonography 
prior to initiation of and during follow-up of lithium therapy [23]. 
Considering the affects of lithium on the thyroid, early diagnosis may 
be ensured by ultrasonographic monitoring, a non-invasive 
examination, in cases undetectable by palpation. In other studies, 
benign non-toxic diffuse goiter has been reported in cases using 
lithium for long periods, with prevalence rates ranging between 3.8 and 
51% [6,8-13].
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WCST Scores Sample Mean SD z p
Mean Score for Total Number of Correct Answers Patient 37.88 9.61 -1.26 0.20
Control 40.72 14.26
Mean Score for Total Number of Wrong Answers Patient 26.12 9.61 1.30 0.14
Control 22.08 12.14
Mean Score for Total Number of Perseverative Patient 16.48 7.78 1.00 0.31
Control 14.04 9.24
Responses
Mean Score for Total Number of Non-
Preservatives Errors Patient 11.80 5.89 1.13 0.26
Control 9.88 6.02
Mean Score for Total Number of Preservatives
errors Patient 14.32 5.94 1.09 0.27
Control 12.20 7.58
Mean Score for Number of Completed Categories Patient 1.96 1.20 -1.09 0.27
Control 2.44 1.82
Mean Score for Percentage of Preservative errors Patient 22.36 9.29 1.10 0.27
Control 19.02 18.5
Mean Score for Number of Responses Used to
Complete the First Category Patient 21.00 13.02 1.74 0.08
Control 15.19 8.22
Mean Score for Percentage of Conceptual Level
Responses Patient 46.98 23.16 -1.25 0.21
Control 56.06 27.65
Mean Score for Failure to Maintain Set Patient 0.80 1.15 0.41 0.67
Control 0.68 0.85
Table 2: Comparisons of WCST test results between the patient and control groups
WCST 1 WCST 2 WCST 3 WCST 4 WCST 5 WCST 6 WCST 7 WCST 8 WCST 9 WCST10
Thyroid Mean r=-0.14 r=0.14 r=0.09 r=0.28 r=0.11 r=-0.16 r=0.11 r=-0.01 r=-0.16 r=-0.19
Right Lobe Volume p=0.50 p=0.50 p=0.64 p=0.17 p=0.59 p=0.43 p=0.59 p=0.95 p=0.43 p=0.36
Thyroid Mean r=-0.08 r=0.08 r=0.06 r=0.19 r=0.05 r=-0.28 r=0.05 r=0.05 r=-0.10 r=0.02
Left Lobe volume p=0.67 p=0.67 p=0.74 p=0.35 p=0.78 p=0.17 p=0.78 p=0.81 p=0.61 p=0.91
Thyroid Mean r=-0.15 r=0.15 r=0.10 r=0.26 r=0.12 r=-0.27 r=0.12 r=0.00 r=-0.16 r=-0.09
Volume p=0.46 p=0.46 p=0.60 p=0.19 p=0.55 p=0.19 p=0.55 p=0.99 p=0.42 p=0.65
Table 3: Comparisons of thyroid USG measurements and WCST results in the patient group
WCST 1: Mean Score for Total Number of Correct Answers, WCST
2: Mean Score for Total Number of Wrong Answers, WCST 3: Mean
Score for Total Number of Preservatives Responses, WCST 4: Mean
Score for Total Number of Non-Preservatives Errors, WCST 5: Mean
Score for Total Number of Preservatives Errors, WCST 6: Mean Score
for Number of Completed Categories, WCST 7: Mean Score for
Percentage of Preservatives Errors, WCST 8: Mean Score for Number
of Responses Used to Complete the First Category, WCST 9: Mean
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Score for Percentage of Conceptual Level Responses, WCST 10: Mean
Score for Failure to Maintain Set
*= Statistically significant, r = Spearman’s test
Thyroid function is within normal levels in most patients
developing goiter. Therefore, it is very important to identify and treat
at early stages any hypothyroidism that may develop due to lithium
administration. Our findings, consistent with the literature, showed
that thyroid volume is increased in patients with bipolar disorder
using lithium.
Because the patient group was composed mainly of patients who
were regularly monitored at a mood disorder clinic, remitted for a
long time, identified as regular drug users, and administered lithium
alone for regulation of their mood disorder, the ability to generalize
these findings to a larger population of bipolar patients is limited.
Another limitation of the study was its small number of patients.
Confounding factors, such as iodine consumption, were difficult to
control and may have influenced the results. Furthermore, the use of a
neuropsychological battery including tests other than the WCST may
be helpful in measuring other potentially relevant cognitive functions.
Our findings displayed that executive dysfunctions as measured
with WCST were no more common in the euthymic bipolar patients
than they were among the healthy controls. Moreover, thyroid volume
in patients with bipolar disorder was not related with WCST
performance. Obviously, more researches with greater number of
patients are required to draw a precise conclusion.
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